The franchising program is offered by MergersUK Limited, a UK Company with its registered office at 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ, United Kingdom.
MergersCorp M&A International provides strategic business advisory services, including preparing companies for growth and capital access. Through partnerships with licensed investment bankers, clients can access tailored capital-raising solutions.
U.S. Investment Banking Securities transactions are exclusively conducted by Spektrum Capital Advisors LLC, a Registered Representative of, and Securities Products offered through, BA Securities, LLC, a FINRA-registered broker-dealer. Check the background of investment professionals associated with this site on Broker Check.
Multiple licensed German pharmaceutical distribution companies holding GDP and narcotics authorizations for the distribution of medical cannabis. These turnkey platforms enable immediate market entry into Germany with fully compliant infrastructure already in place.
A fully licensed pharmaceutical distribution entity in Germany, purpose-built for the medical cannabis sector. The business operates under a streamlined, asset-light model, leveraging established third-party partners for logistics, compliance, and quality assurance, ensuring efficient operations and a scalable foundation for rapid market entry.
Listing Details
Fully licensed German medical cannabis wholesaler authorized to register, distribute, and commercialize medical cannabis products.
Clean corporate structure with no debt, pre-revenue status, and all required licenses already in place.
Existing agreements with licensed warehousing and logistics providers for secure storage and distribution.
Appointed Responsible Person for narcotics and medical cannabis release, who is willing to remain with the business.
The licensing process typically takes 12–18 months, offering a significant immediate time-to-market advantage for an acquirer.
Well-suited for international producers, distributors, or investors seeking a compliant, turnkey platform to enter Germany or the broader EU market.
Multiple licensed German pharmaceutical distribution companies holding GDP and narcotics authorizations for the distribution of medical cannabis. These turnkey platforms enable immediate market entry into Germany with fully compliant infrastructure already in place.
A fully licensed pharmaceutical distribution entity in Germany, purpose-built for the medical cannabis sector. The business operates under a streamlined, asset-light model, leveraging established third-party partners for logistics, compliance, and quality assurance, ensuring efficient operations and a scalable foundation for rapid market entry.
Listing Details
Fully licensed German medical cannabis wholesaler authorized to register, distribute, and commercialize medical cannabis products.
Clean corporate structure with no debt, pre-revenue status, and all required licenses already in place.
Existing agreements with licensed warehousing and logistics providers for secure storage and distribution.
Appointed Responsible Person for narcotics and medical cannabis release, who is willing to remain with the business.
The licensing process typically takes 12–18 months, offering a significant immediate time-to-market advantage for an acquirer.
Well-suited for international producers, distributors, or investors seeking a compliant, turnkey platform to enter Germany or the broader EU market.
Description
Multiple licensed German pharmaceutical distribution companies holding GDP and narcotics authorizations for the distribution of medical cannabis. These turnkey platforms enable immediate market entry into Germany with fully compliant infrastructure already in place.
A fully licensed pharmaceutical distribution entity in Germany, purpose-built for the medical cannabis sector. The business operates under a streamlined, asset-light model, leveraging established third-party partners for logistics, compliance, and quality assurance, ensuring efficient operations and a scalable foundation for rapid market entry.
Listing Details
Basic Details
Target Price:
$ 0
Gross Revenue
TBD
EBITDA
TBD
Business ID:
L#20261068
Country
Germany
Detail
Published on May 21, 2026 at 11:23 am. Updated on May 21, 2026 at 11:23 am